You are invited to take part in a research study if you have chronic and/or subacute cutaneous lupus erythematosus (CLE) (a medical condition similar to lupus which impacts your skin, hair, and other body surfaces).

The research study is testing a new treatment for chronic and/or subacute cutaneous lupus erythematosus. The new treatment is called AnifrolumabWestmead Hospital is undertaking a lupus clinical trial with people that having the following  that we are recruiting for here at Westmead Hospital.

Cutaneous Lupus Erythematosus Clinical Trial (Lavender, Astrazeneca)

• Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Anifrolumab in Adults with Chronic and/or Subacute Cutaneous Lupus Erythematosus who are Refractory and/or Intolerant to Antimalarial Therapy
• Can have systemic involvement
• 120mg anifrolumab subcutaneously once weekly
• 24 weeks of blinded placebo vs active drug period followed by 28 weeks of open-label treatment with anifrolumab

If you are interested, please reach out to the following via these emails:

1. William.Luu@health.nsw.gov.au
2. WSLHD-Dermatology-ClinicalTrials@health.nsw.gov.au

Attached is the Participant Information document that is more detailed for anyone who is particularly interested.

Thank you again for your time and support!